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0022-2836 © 2007 Elsevier Ltd. Open accesThe pathogenic bacteria Bordetella parapertussis and Bordetella bronchiseptica
express a lipopolysaccharide O antigen containing a polymer of 2,3-
diacetamido-2,3-dideoxy-L-galacturonic acid. The O-antigen cluster con-
tains three neighbouring genes that encode proteins belonging to the short-
chain dehydrogenase/reductase (SDR) family,wbmF, wbmG and wbmH, and
we aimed to elucidate their individual functions. Mutation and comple-
mentation implicate each gene in O-antigen expression but, as their putative
sugar nucleotide substrates are not currently available, biochemical
characterisation of WbmF, WbmG and WbmH is impractical at the present
time. SDR family members catalyse a wide range of chemical reactions
including oxidation, reduction and epimerisation. Because they typically
share low sequence conservation, however, catalytic function cannot be
predicted from sequence analysis alone. In this context, structural
characterisation of the native proteins, co-crystals and small-molecule
soaks enables differentiation of the functions of WbmF, WbmG andWbmH.
These proteins exhibit typical SDR architecture and coordinate NAD. In the
substrate-binding domain, all three enzymes bind uridyl nucleotides.
WbmG contains a typical SDR catalytic TYK triad, which is required for
oxidoreductase function, but the active site is devoid of additional acid–
base functionality. Similarly, WbmH possesses a TYK triad, but an
otherwise feature-poor active site. Consequently, 3,5-epimerase function
can probably be ruled out for these enzymes. TheWbmF active site contains
conserved 3,5-epimerase features, namely, a positionally conserved cysteine
(Cys133) and basic side chain (His90 or Asn213), but lacks the serine/
threonine component of the SDR triad and therefore may not act as an
oxidoreductase. The data suggest a pathway for synthesis of the O-antigeness: jking01@uoguelph.ca.
ually to this work.
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750 SDR Enzymes in Bordetella O-antigen Biosynthesisprecursor UDP-2,3-diacetamido-2,3-dideoxy-L-galacturonic acid and illus-
trate the usefulness of structural data in predicting protein function.© 2007 Elsevier Ltd. Open access under CC BY license. Keywords: short-chain dehydrogenase/reductase; X-ray crystallography;
Bordetella; lipopolysaccharide; O-antigen biosynthesisEdited by I. WilsonIntroduction
The acceleration of genome sequencing has created
a challenge for modern biology, namely, interpreta-
tion of the vast and growing amount of genetic
information in the databases. Search algorithms such
as the basic local alignment search tool (BLAST)1 can
efficiently find related genes, but only in a small
minority of cases is the precise function of a novel
enzyme equivalent to that of the highest scoring hit.
In straightforward cases the output is useful to
generate hypotheses for the novel enzyme's function,
based on common catalytic chemistry, substrates or
both, and these postulates are then amenable to direct
biochemical investigation. To make full use of
genome data it is important thatwhere such standard
bioinformatic analysis cannot predict precise roles
and biochemical function assays are not possible,
tools are developed to differentiate the functions of
genes. A good example of such a challenging case is
where gene products are annotated as short-chain
dehydrogenase/reductases (SDRs). Members of this
family share low sequence identity (typically 15–
30%) and catalyse a wide range of chemical reactions,
including oxidation, reduction, epimerisation, dehy-
dration and decarboxylation (reviewed in Ref. 2).
Bordetella parapertussis and Bordetella bronchiseptica
are pathogens of mammals. B. bronchiseptica is as-
sociated with respiratory tract infections in many
animals including acute tracheobronchitis in dogs
(kennel cough)3 and atrophic rhinitis in pigs,4
whereas B. parapertussis can cause whooping cough
in humans.5 A separate lineage of B. parapertussis
infects sheep.6
The major component of the outer leaflet of the
outer membrane in Gram-negative bacteria is lipo-
polysaccharide (LPS). The complete structure of this
macromolecule in B. bronchiseptica and B. parapertus-
sis has been recently described.7 The lipid A domain
of LPS, which consists of a diglucosamine backbone
substituted with fatty acyl chains, forms the outer
leaflet of the outer membranes of the bacteria. Lipid
A is linked to a complex, branching oligosaccharide
known as the core. Lipid A-core comprises a pro-
portion of the LPS that is exposed on the cell surface
and is known as band B. In B. bronchiseptica, lipid
A-core can be substituted with a trisaccharide and
this structure is known as band A. Synthesis of the
band A trisaccharide requires functions encoded in
the wlb gene cluster (previously named bpl).8
Both B. bronchiseptica and B. parapertussis also
substitute their LPS with an O antigen. This O anti-
gen contains 12 to 15 2,3-diacetamido-2,3-dideoxy-L-
galactosaminuronic acid (L-GalNAc3NAcA) resi-
dues9 and is required for full virulence in animaland in vitro models of infection.10 O-antigen bio-
synthesis requires genes in the wbm cluster that is
adjacent to the wlb genetic locus. The wbm locus
contains three neighbouring SDR genes (wbmF,
wbmG and wbmH), all of which have been annotated
as nucleotide-sugar epimerases/dehydratases.
The structure of complete O antigen and the
homology of wbm genes with genes of known func-
tion have led us to propose a pathway for biosynth-
esis of this polysaccharide and we are currently
testing various steps in this scheme as part of an
ongoing project to determine the functions of all 24
wbm genes. This report specifically concerns the
roles of the SDR genes wbmF, wbmG and wbmH.
O-antigen residues are synthesised as sugar nuc-
leotide precursors. The probable substrate for wbm
locus-encoded biosynthesis of the nucleotide-acti-
vated L-GalNAc3NAcA is UDP-2,3-diacetamido-2,
3-dideoxy-D-mannuronic acid (UDP-D-ManNAc3-
NAcA). This compound is related to the L-galacto
configuration by inversion of the stereochemistry at
the hexose 3 and 5 positions. In the bordetellae,
UDP-D-ManNAc3NAcA is formed as a precursor for
band A trisaccharide synthesis by 2-epimerisation of
UDP-2,3-diacetamido-2,3-dideoxy-D-glucuronic acid,
catalysed by WlbD.11 Because there are precedents
for either a single12 or multiple13–16 SDR enzymes
catalysing 3,5-epimerisation conversions of sugar
nucleotides, we hypothesise that one or more of
WbmF, WbmG and WbmH operate in this bio-
synthetic pathway to catalyse the conversion of
UDP-D-ManNAc3NAcA to UDP-2,3-diacetamido-
2,3-dideoxy-L-galacturonic acid (UDP-L-GalNAc3-
NAcA). Because of the low percentage conversion
of the WlbD-catalysed reaction, UDP-D-ManNAc3-
NAcA is not currently available for biochemical
studies and therefore this hypothesis cannot be
directly tested at the present time.
In this report we demonstrate the involvement of
wbmF, wbmG and wbmH in O-antigen expression by
mutation of the genes in B. bronchiseptica. Because
the putative substrate is unavailable, we elected to
probe the catalytic functions of WbmF, WbmG and
WbmH by characterising these proteins' three-
dimensional structures. With soaking and co-crys-
tallisation experiments, densities corresponding
to cofactors and nucleotide portions of substrate
analogues can be identified within the active sites.
Biochemical and crystallographic studies have de-
fined the structural basis for the catalytic chemistries
of a range of other SDR enzymes (reviewed in Ref.
17). Our knowledge of these structure–function
relationships enables us to interpret the structures
of the wbm SDRs. We have analysed the potential for
acid–base chemistry in the active sites to differenti-
751SDR Enzymes in Bordetella O-antigen Biosynthesisate their potential roles in vivo. Based on the com-
position of O antigen, the genetic context of these
wbm genes and information from the structural
studies, we propose roles for these genes in
O-antigen biosynthesis. The results demonstrate
the usefulness and limitations of X-ray data in
elucidating biochemical pathways where catalytic
activity cannot be directly measured.Results
Mutational analysis of wbmF, wbmG and wbmH
To test the hypothesis thatwbmF,wbmG andwbmH
are involved in O-chain biosynthesis, each gene was
disrupted by insertion of a tetracycline-resistance
cassette. Mutation of the chromosomal genes was
confirmed by Southern hybridisation (data not
shown). The effects of these mutations were assessed
by silver-stained SDS-PAGE analysis and immuno-
blotting of mutant LPS (Fig. 1). Mutation of wbmG or
wbmH results in apparent abrogation of O-antigen
synthesis, as the LPS from these mutants lacks O
band as detected by either silver stain or Western
blot. O-antigen expression in the wbmF mutant,
CNF0a, is dramatically reduced compared with theFig. 1. (a) Silver stain analysis and (b) Western immu-
noblot of duplicate SDS-PAGE gels showing the LPS
profiles of wild-type B. bronchiseptica (CN7635E) and
CN7635E-derived mutants in wbmF (CNF0a), wbmG
(CNG1a) and wbmH (CNH1d) and mutants carrying the
complementation vectors for wbmF (pCompF), wbmG
(pCompG) and wbmH (pCompH) or the empty vector
(pCompEmpty). The positions of the B. bronchiseptica
A-band (A) and B-band (B) species are indicated as well as
the position of LPS that contains O antigen (O). The
primary monoclonal antibody used in (b) that recognises
O-band LPS was D13B11.35wild type, but this strain retains its ability to express
a small amount of material with the electrophoretic
mobility of O-band LPS and which binds the
O-antigen-specific monoclonal antibody, D13B11.
Each of the mutations was complemented by
expression of the cognate wild-type allele in trans
(Fig. 1). Each coding sequence was cloned into the
broad host range vector pBBR1MCS(kan) under the
control of the flaA promoter to generate complemen-
tation vectors. Complementation of the wbmG and
wbmH mutations restored O-antigen expression to
near wild-type levels. O-antigen expression in the
complemented wbmF mutant was increased relative
to the wbmF mutant, but was still considerably less
than inwild type. The reason for incomplete comple-
mentation of the wbmF mutation is unknown, but is
not likely to be due to polar effects of the mutation
because, due to the organisation of genes in the wbm
locus, wbmF is at the 3′ end of an operon.18 Introduc-
tion of the empty complementation vector had no
effect on O-antigen expression in any of the mutants.
The gene products WbmF, WbmG and WbmH
are all in the extended SDR family
The SDR family is divided into the classical and
extended subfamilies primarily on the basis of pro-
tein length and the sequence pattern of the glycine-
rich cofactor-binding region close to the N terminus.
According to both criteria, the products of wbmF,
wbmG and wbmH, which are predicted to have 357,
310 and 313 amino acids, respectively, and all have
the GxxGxxG motif near the N terminus, are
extended SDRs2 (Fig. 2).
WbmGandWbmHare closely related to eachother,
sharing 38% amino acid identity. WbmF, WbmG and
WbmH are all homologous to Pfam01370 (NAD-
dependent epimerase/dehydratase family). The
most closely related, characterised homologues of
these Wbm SDRs in the protein databases are
deoxythymidine diphosphate (dTDP)-glucose 4,6-
dehydratases from Escherichia coli and Streptomyces
venezuelae with 27% or 28% sequence identity
(Table 1).19 This level of sequence conservation
between members of the SDR family does not imply
conservation of either catalytic chemistry or sub-
strate; rather this functional information can be
better determined by examination of the residues at
key positions in the active sites and binding pockets.
Several conserved motifs within the extended SDR
subfamily facilitate alignment of sections of the
Wbm SDR sequences with homologues (Fig. 2) but
many of the critical functional amino acids are
located outside of these motifs, and with this low
level of conservation, it is not possible to make full
sequence alignments with confidence that all of
these residues are correctly identified.
Crystallisation of His6-WbmF, His6-WbmG and
His6-WbmH
Thus far the data implicated each of these wbm
SDRs in O-antigen synthesis, but did not indicate
Fig. 2. Conserved motifs in extended SDR enzymes. Sections from Wbm SDR protein sequences are aligned with the
characteristic motifs of the extended SDR subfamily. Except for the alignments with Wbm sequences, the information in
this table is from Ref. 2. Lowercase letters represent conserved biophysical properties of amino acid side chains: x, any
residue; h, hydrophobic; c, charged; p, polar; a, aromatic. Conservation of motif features in Wbm proteins is indicated by
shading.
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elucidate their individual functions we characterised
the gene products by X-ray crystallography. The
overexpression, purification and crystallisation of
these proteins are described elsewhere.20 The struc-
tures discussed in the present work are summarised
in Table 2.
General architecture of His6-WbmF, His6-WbmG
and His6-WbmH
These proteins all exhibit the typical SDR family
architecture (Fig. 3). The structures each comprise
two domains. The first of these is the N-terminalTable 1. Closest homologues of WbmF, WbmG and
WbmH in the protein databases
Protein Closest homologue
Sequence
identity (%) References
WbmF dTDP-Glc 4,6-dehydratase,
RffG, E. coli
27 19
WbmG dTDP-Glc 4,6-dehydratase,
DesIV, S. venezuelae
28 23
WbmH dTDP-Glc 4,6-dehydratase,
DesIV, S. venezuelae
28 23
The sequence identity reported between each Bordetella protein
and its closest homologue is based on the alignments produced by
a third-iteration position-specific iterated BLAST.Rossmann fold domain in which a central β sheet is
flanked by two layers of α helices. The cofactor-
binding motif GxxGxxG is located at the C-terminal
edge of this β sheet, which has seven parallel β
strands running in the order 3, 2, 1, 4, 5, 6, 7. The
second domain is largely made up of C-terminal
sequence and contains all of the residues involved in
binding of the nucleotide portion of the substrate.
The catalytic sites in SDR enzymes are located at the
interface of these two domains where, in sugar-
nucleotide-modifying enzymes, the substrate hexose
is brought into proximity with the cofactor nicoti-
namide ring. The main architectural differences
between these three proteins lie in their C-terminal
regions (Fig. 3). The C terminus of His6-WbmG
consists of a loop that stretches out from the
C-terminal domain to interact with the Rossmann
domain. In His6-WbmH, this loop is not visible in
the density, although this difference may not reflect
any distinction between the real structures of the
two proteins in solution. In WbmF, the last 30
residues form a large bent helix that covers two faces
of the C-terminal domain. There is also an insertion
of 14 amino acids in WbmF relative to the other
structures, including all residues from Gly198 to
Arg212. This extra loop extends over the nicotina-
mide end of the cofactor-binding pocket.
SDRs typically form dimers or higher oligomers.
The crystal packing of these proteins suggests that
WbmF, WbmG and WbmH have the conserved
Table 2. X-ray structures refinement data
PDB ID 2PZJ 2Q1T 2Q1U 2Q1S 2PZK 2PZL 2PZM 2Q1W
Crystal WbmF-NAD+ WbmF-NAD+-UDP soak
WbmF-NAD+-UDP
co-crystal WbmF-NADH
WbmG-GDP-Man
soak
WbmG-UDP-glucose
soak
WbmG-UDP
co-crystal WbmH native
Ligands NAD+ NAD+, UDP NAD+, UMP NADH NAD NAD, UMP NAD, UDP NAD
Refinement
Resolution (Å) 40–1.90 30–1.75 50–1.70 50–1.50 30–2.10 30–2.40 30–2.00 80–2.20
No. unique reflections 27,275 33,895 81,311 57,271 38,661 27,549 51,158 49,975
No. reflections used
in refinement
25,919 32,210a 77,250a 54,327 36,601a 26,162 48,524a 47,385
Rwork/Rfree 16.1/20.4 18.3/21.9 17.7/21.1 19.1/22.6 18.8/24.2 18.6/23.5 17.1/22.1 17.9/22.7
No. atoms 2774 2835 5791 2887 5048 4954 5359 7267
Protein 2538 2557 5154 2596 4643 4670 4750 6820
Ligand/ion 44 69 142 44 89 130 136 132
Water 192 209 495 247 316 154 473 415
B-factors
Protein 30.5 41.3 19.7 44.9 34.3 34.6 27.2 29.1
Ligand/ion 21.2 35.6 27.8 27.4 27.5 27.8 39.7 24.4
Water 36.9 40.3 38.2 45.0 38.8 33.3 39.4 31.8
RMSD
Bond lengths (Å) 0.014 0.015 0.015 0.014 0.014 0.015 0.017 0.016
Bond angles (°) 1.46 1.75 1.54 1.63 1.60 1.59 1.70 1.51
Ramachandran plotb
Favoured (%) 98.1 98.2 98.9 98.8 98.4 97.2 97.9 97.3
Allowed (%) 1.5 1.5 1.1 0.9 1.1 2.1 1.6 2.4
Outliers (%) 0.3 0.3 0.0 0.3 0.5 0.7 0.5 0.3
Data collection statistics have been previously described.20 R=∑bFobs−FcalcN/∑bFobsN.
a The free set of reflections was included in the final round of refinement.
b Ramachandran plot analysis was performed using RAMPAGE (http://mordred.bioc.cam.ac.uk/~rapper/rampage.php) for which expected values for well-refined, high-resolution structures are
98% favoured, 2% allowed.65
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Fig. 3. Nucleotide binding in WbmF, WbmG and WbmH. Proteins are oriented with the Rossmann domains in the
lower part of each structure. Cartoons are used to represent protein backbone; bound nucleotides are shown as ball-and-
stick and key protein side chains as sticks. The boxed panels show details of UMP-binding pockets in (a) His6-WbmF, UDP
co-crystal, (b) His6-WbmG crystal soaked with UDP-glucose and (c) His6-WbmH. In (a) and (b), UMP is shown as sticks,
and spheres represent atoms within 3.5 Å of the bound nucleotide. Probable hydrogen-bonding interactions are shown as
dashed lines. In (c) spheres represent ordered water molecules in this binding pocket. Carbon atoms are coloured rainbow
for protein, white for bound nucleotides; oxygen atoms are coloured red; nitrogen is blue and phosphorus orange.
754 SDR Enzymes in Bordetella O-antigen Biosynthesisfour-helix bundle usually found at the dimer inter-
face. Analytical gel filtration chromatography indi-
cated a hydrodynamic radius for each of these
proteins consistent with either a monomer or dimer
(data not shown). We conclude, therefore, that these
proteins are present in solution predominantly in
dimer form. In the WbmG and WbmH structures,
the dimer interaction buries 1316 Å2 (5.7% of total
protein surface) and 1562 Å2 (7.2%) of surface per
dimer, respectively. In the WbmF structure the
interface region is extended to include a short anti-
parallel β sheet composed of the residues Ile151 to
Ser153 from each monomer as well as the loops
that connect these strands to the bundle (Leu154
to Pro160); 2131 Å2 is buried in the WbmF dimer
interface, which is equivalent to 8.6% of the total
protein surface. In all three cases, the majority of the
residues buried at these interfaces are hydrophobic
or aromatic.
Cofactor binding
NAD can be modelled into the electron density in
all three proteins. His6-WbmG and His6-WbmH
copurify with this compound from the E. coli
expression host, but in order to stabilise the proteinin solution His6-WbmF required the addition of
exogenous cofactor,20 and this is the most likely
source of this molecule in these His6-WbmF struc-
tures. The preference in each case for NAD cofactor
as opposed to NADP is indicated by the close
interaction (2.7 Å hydrogen bonds) of an aspartate
side chain with the 2′-hydroxyl of the adenylic
ribose. This side chain would disfavour binding of
NADP by both steric and electrostatic repulsion of
the NADP 2′-phosphate. In some SDR structures
[e.g., GDP-4-keto-6-deoxymannose 3,5-epimerase/
reductase (GMER)21 and RmlD22] the bound cofac-
tor has direct access to solvent, indicating a pathway
via which spent NAD/NADP can be replaced from
solution. In these structures, the bound cofactor is
buried within the core of the protein; in the case of
the His6-WbmF structure, the 14-amino-acid inser-
tion supplies an additional occluding loop, further
blocking release of cofactor in this conformation.
Binding of substrate
Soaking and co-crystallisation experiments with
His6-WbmF and His6-WbmG revealed the binding
mode for the nucleotide portion of the sugar nucleo-
tide substrates of these enzymes (Fig. 3). The X-ray
755SDR Enzymes in Bordetella O-antigen Biosynthesisdata from a His6-WbmG crystal soaked with UDP-
glucose revealed extra density that could be
modelled as far as the α-phosphate. The location of
this molecule is consistent with the nucleotide-
binding site for SDR homologue structures and
with the hydrogen-bonding chemistry expected to
bind uridine. No density was visible corresponding
to the hexose portion of the soaked compound nor
the second phosphate, suggesting that either this
portion of the molecule is disordered within the
crystal, or the compound was partially hydrolysed
and the smaller uridine monophosphate (UMP)
preferentially soaked into the substrate-binding
pocket. In either case, the data indicate that the
glucose-1-phosphate moiety of UDP-glucose is not
strongly bound in a single conformation by WbmG.
A similar soaking experiment but with GDP-
mannose did not indicate any binding of this sugar
nucleotide (data not shown), indicating a possible
preference for the uracil base. The hydrogen bond-
ing between the WbmG pocket and UMP suggests a
basis for this preference (Fig. 3b). Although we were
unable to obtain any complex of WbmH with a
substrate analogue bound, the nucleotide-binding
domain of WbmH is conserved in sequence and
structure with WbmG, implying identical specificity
and a common binding mode for the nucleoside
portion of their substrates (Fig. 3c). UDP density to
the α-phosphate is also visible in the WbmF/NAD/
UDP ternary complex. The UMP density in this
structure and the chemistry of its interaction with
the protein suggests that this protein, like WbmG
and WbmH, recognises a UDP-sugar substrate.
Both α and β nucleotide phosphates could be
modelled in the data from a UDP soak into aWbmF-
NAD+ co-crystal and co-crystallisation of His6-
WbmG with UDP. In both structures the β-phos-
phate is coordinated by a conserved arginine (Fig. 4a
and b), although the precise location of this
phosphate is different in the two structures and
both are inconsistent with the β-phosphate positions
of bound substrate in the structure of a D128N,
E129Q mutant of dTDP-glucose 4,6-dehydratase,
DesIV, from S. venezuelae (Fig. 4c).23 In this DesIVFig. 4. The UDP-binding pockets are shown for (a) His6-
co-crystal. Spheres represent atoms within 3.5 Å of the bound
cofactor. (c) dTDP-glucose bound in the active site of a D128N
from S. venezuelae (PDB ID 1R6D).23 The substrate-binding
comparison of the relative positions of the UDP diphosphatesstructure [Protein Data Bank (PDB) ID 1R6D] the
position of the substrate is consistent with the
necessary overlap of molecular orbitals required
for hydride transfer from the glucose C-4 to the
cofactor. It is likely, therefore, that the β-phosphate
positions in WbmF and WbmG structures do not
represent the positions of equivalent phosphates
when the native substrates for these enzymes are
bound in the active site.
One common feature of substrate binding in SDR
enzymes is pi stacking of the nucleobase with an
amino acid side chain. In WbmF, this interaction
involves Glu231 (Fig. 3a). Unusually, in WbmG the
pi-stacking residue (Phe190) is the one that hydro-
gen bonds with the uracil N-3 (Fig. 3b). In WbmF,
E. coli UDP-galactose 4-epimerase (GalE),24 S. vene-
zuelae DesIV,23 and Pseudomonas aeruginosa WbpP,25
the hydrophobic contact is provided by the residue
in the n+2 position, whose backbone amide hydro-
gen bonds with the base's O2 group (Fig. 5). This
unusual feature of the substrate binding in WbmG
could not have been predicted from sequence
alignments alone.
Potential catalytic chemistry
SDR enzymes have a conserved catalytic triad that
is involved in their oxidoreductase activity and that
is classically composed of a spatially conserved
serine, tyrosine and lysine (SYK) triad, for example,
Ser142, Tyr166 and Lys170 in WbpP. The first
member of this triad is sometimes found as a
threonine (TYK),23 and the tyrosine can be replaced
by a methionine (SMK).26 The SDR triad is con-
served in WbmG and WbmH as TYK but in WbmF
Ala131 superimposes onto the Ser/Thr position
(Fig. 6a).
In the context of O-antigen synthesis in Bordetella
we are interested in the potential of the wbm SDR
enzymes to catalyse secondary reactions of their
substrates beyond the oxidoreductase reactions
common to all SDRs. Of particular significance is
the identification of a potential 3,5-epimerase.
Despite the lack of a structure in which a fullWbmF, soaked with UDP and (b) the His6-WbmG, UDP
UDP; NAD indicates the nicotinamide ring of the NAD
, E129Q mutant of dTDP-glucose 4,6-dehydratase DesIV
pockets are all shown from the same angle to enable
in (a) and (b) with the phosphates in dTDP-glucose in (c).
Fig. 5. Pi-stacking interactions in binding of uracil or
thymine. Amino acids that directly interact with the
substrate nucleobase are shown for B. bronchiseptica
WbmF and WbmG, E. coli GalE, S. venezuelae DesIV and
P. aeruginosa WbpP with carbon atoms coloured yellow.
UMP or dTDP from each structure is shown with carbon
atoms in white. Amino acid side chains that have pi-
stacking interactions with the base are labelled, and
hydrogen-bonding interactions with the peptide backbone
are indicated as dashed lines. Images for GalE, DesIV and
WbpP were prepared using PDB files 1LRL,24 1R6D23 and
1SB8,25 respectively.
756 SDR Enzymes in Bordetella O-antigen Biosynthesissugar nucleotide substrate analogue is bound, the
cavity into which the substrate hexose binds is easily
identifiable by comparison with homologue struc-
tures and because it is necessarily interposed
between the UMP-binding site and the cofactor
nicotinamide ring. The active sites of WbmG and
WbmH are devoid of amino acid side chains capable
of acid–base chemistry except for their respective
TYK triads and, in WbmH, Ser176. SDR enzymes
that catalyse 3,5-epimerisation of their substrates
have a spatially conserved catalytic cysteine and abasic side chain. In GMER these residues are Cys109
and His179;21 in GDP-mannose 3,5-epimerase
(GME) they are Cys145 and Lys217.12 In WbmG
and WbmH these amino acids superimpose onto
hydrophobic side chains, but in WbmF this catalytic
cysteine is conserved (Cys133) and there are two
candidates for the basic side chain, Asn213 and
His90 (Fig. 6b). Cys133 is disordered in all of our
WbmF crystals, indicating that an element of
induced fit may be required to bring all of the
active-site components into place. His90 has a very
unusual backbone conformation, with a cis peptide
bond to the following residue. This is strongly sug-
gestive of a functional role for this residue, since
such conformations are rarely observed except
where they are required to place a key side chain
in the active site.
Modelling of the putative substrate into the
WbmF active site
The analysis of the potential catalytic chemistry
of WbmF suggested that its role in O-antigen
biosynthesis may be to catalyse the 3,5-epimerisa-
tion required in the overall conversion of UDP-D-
ManNAc3NAcA to UDP-L-GalNAc3NAcA. The 4-
keto derivative of UDP-D-ManNAc3NAcA is
therefore a likely substrate or reaction intermedi-
ate for WbmF. This compound contains a bulkier
sugar than any of the substrates of the characterised
sugar-nucleotide-modifying SDRs. An important
test of our proposed pathway is that the enzymes
must be able to accommodate these unusually large
substrates. We modelled 4-keto UDP-D-ManNAc3-
NAcA into the active site of WbmF (Fig. 7). This
showed that it is feasible for the substrate to occupy
the active site of WbmF in a manner that is consis-
tent with the experimentally determined binding
site for UMP, the proximity of the most likely
catalytic site, and good geometry.Discussion
The abrogation or reduction of O-antigen expres-
sion as a result of wbmF, wbmG or wbmH mutations
implicates all three genes in the biosynthesis of this
molecule, and is consistent with the hypothesis that
these three adjacent SDR genes catalyse the UDP-D-
ManNAc3NAcA to UDP-L-GalNAc3NAcA con-
version, which is probably required for O-antigen
synthesis.
Structural analysis of these three wbm SDR gene
products also enables us to distinguish between
them in terms of potential catalytic chemistry. Both
WbmG and WbmH have the conserved SDR
catalytic triad (TYK in these cases), which suggests
that they should be competent to function as
oxidoreductases. In both of these enzymes, the
pocket that surrounds the active site is hydrophobic
and featureless compared with other SDR enzymes;
the lack of side chains capable of acid–base chemistry
indicates that the functions of these enzymes are
Fig. 6. Comparison of active-site residues in WbmF, WbmG and WbmH compared with WbpP25 and GMER. (a) The
SDR catalytic triad is conserved in WbmG and WbmH but not in WbmF where the residue normally found as serine
or threonine superimposes onto the position of Ala131. (b) GMER is shown as an example of an SDR that catalyses
3,5-epimerisation of its substrate.21 The GMER epimerase catalytic residues Cys109 and His179 superimpose onto
hydrophobic residues in WbmG and WbmH. WbmF has side chains in these positions (Cys133 and Asn213) that may be
capable of acid–base chemistry. *Cys133 is not resolved in the WbmF crystal; its position here is inferred from the
neighbouring residue (Gly132), which is visible in the electron density.
757SDR Enzymes in Bordetella O-antigen Biosynthesislikely to be limited to oxidation and/or reduction
and probably rules out specific 3,5-epimerase activ-
ity. The hydroxyl of Ser176 inWbmHmay be capable
of facilitating proton exchange; however, an amino
acid pair capable of acid–base chemistry is required
for 3,5-epimerase function.
Some SDRs that catalyse both oxidation and
reduction bind cofactor irreversibly and recycle it
within the active site.27 In other SDRs, this binding is
reversible and the cofactor-binding site is situated at
the bottom of a solvent-accessible groove (e.g., in
E. coli GMER, PDB ID 1BWS).28 No such groove is
visible in the WbmF, WbmG and WbmH structures,
where the cofactor-binding sites are almost comple-
tely occluded. However, we do not take this ob-
servation as being diagnostic of irreversible cofactor
binding in these proteins for the following reasons.
Firstly, exogenous cofactor is required for WbmF to
be stable in solution with respect to precipitation.20
Presumably either cofactor that copurifies with
WbmF can be released, resulting in unfolding and
aggregation of the protein, or apo-WbmF must bind
cofactor supplied from the medium in order to fold
correctly. Either case would suggest that NAD can
be exchanged between WbmF and solvent. Sec-
ondly, human GalE reversibly binds cofactor,29 and
yet does not have an open binding site like that of
GMER. Finally, a conversion of configuration from
D-manno to L-galacto can be catalysed by a single
tight NAD+-binding enzyme such as GME,12 but
we cannot envisage a pathway in which two or
three such enzymes contribute to this transforma-
tion. Instead, we suggest that the protein loops that
cover the NAD-binding site may be flexible and
move to allow release and replacement of spent
cofactor.WbmF lacks the serine/threonine of the SDR
catalytic triad. The conservation of the classical SDR
catalytic triad is not absolute amongst members of
the family. For example, in the very unusual SDR
enzyme, biliverdin IXβ reductase (which catalyses
the reduction of a range of substrates including
some flavins and non-α-isomers of biliverdin), a
histidine occupies the usual place of the catalytic
lysine and tyrosine residues.30 The shapes and
electron delocalisation exhibited by biliverdin IXβ
reductase substrates imply that compared with the
putative substrates of the Wbm SDR enzymes, they
will have rather special requirements for binding
geometry and reaction intermediate stabilisation
during catalysis. In those SDRs that oxidise or re-
duce sugar nuclotides at the hexose C-4 position,
however, the catalytic triad serine/threonine resi-
due is important because it modifies the pKa of the
C-4 hydroxyl by forming a short hydrogen bond.23
Mutation of the triad threonine (Thr134) to alanine
in E. coli dTDP-Glc 4,6-dehydratase results in a 200-
fold drop in kcat,
31 whereas mutation of Ser124 to
alanine in E. coli GalE reduces epimerase activity
(kcat) almost 3000-fold.
32 The incomplete WbmF
catalytic triad raises doubts about the competence of
this enzyme as a sugar nucleotide oxidoreductase. It
is possible that the function of the missing side chain
is provided by another active-site residue; this
implies a different substrate-binding geometry and
further studies will be required to investigate this
possibility. Conversely, if a standard substrate-
binding orientation is assumed, the active site of
WbmF resembles that of 3,5-epimerases and our
structures of this protein identify Cys133 and either
Asn213 or His90 as potential mediators of proton
exchange in the epimerisation reaction—one group
Fig. 7. A model of the proposed substrate in the
binding site of WbmF. (a) Overview of modelled interac-
tion of WbmF with the 4-keto derivative of UDP-D-
ManNAc3NAcA. Protein is shown as cartoon, with key
(labelled) side chains, NAD and sugar nucleotide in sticks.
The elements of the UDP-sugar found in the experimental
structure have paler colours to highlight the modelled
sections. (b) and (c) Close-up of the modelled sugar ring
(shown as spheres) demonstrates that there are no clashes
between the proposed ligand and the protein surface. The
two views show opposite sides of the sugar: (c) shows the
surface with the imaged slab cut at the level of the first
sugar atom, with NAD surface also removed for clarity.
Carbon atoms are yellow for protein, white for the NAD
and cyan for 4-keto UDP-D-ManNAc3NAcA; oxygen is
red, nitrogen is blue, phosphorus is orange and sulfur is
purple.
758 SDR Enzymes in Bordetella O-antigen Biosynthesisabstracts a proton from the sugar while the other
donates a proton to the opposite face.
By modelling the compound 4-keto UDP-D-Man-
NAc3NAcA into the WbmF structure we have
demonstrated that there is space within this active
site to accommodate this bulky sugar nucleotide.
Other solutions produced in the modelling process
demonstrated alternative plausible substrate posi-Fig. 8. Proposed pathway for the synthesis of UDP-L-GalNtions (data not shown). For this reason, we do not
suggest that the solution presented here (Fig. 7)
represents the true active conformation. While we
did not attempt similar modelling experiments with
WbmG and WbmH, visual inspection of these
structures indicates that they also have spacious
active sites compared with other SDRs and can
therefore accommodate diacetamido uronic acids in
their hexose-binding pockets.
We therefore propose the following biosynthetic
pathway (Fig. 8) for the 3,5-epimerisation of UDP-
D-ManNAc3NAcA: One of the putative oxidore-
ductases, WbmG or WbmH, catalyses the initial
oxidation at C-4, and the other oxidoreductase is
responsible for the final reduction step. Introduction
of the keto group lowers the pKa of the C-3 and C-5
hydrogen atoms, allowing WbmF to catalyse proton
exchange effecting 3,5-epimerisation. This scheme is
the most consistent with all of the available data.
The function suggested for WbmF is very unusual in
that we suggest that this enzyme does not catalyse
oxidation or reduction of its substrate. If this is the
case, WbmF would be the first such member of
the SDR family, and this would imply that the co-
factor in WbmF has a purely structural role, without
participating in the catalytic cycle. It has been
suggested that the transcriptional regulation protein
NmrA from Aspergillus nidulans is a NAD-binding
SDR family member that is not an enzyme at all.
NmrA appears to function in control of nitrogen
metabolism through physical interaction with the
GATA family transcription factor AreA, possibly
by controlling the rate of entry of AreA into the
nucleus,33 and the structural equivalents of the SDR
triad tyrosine and serine/threonine in NmrA are
Met127 and Met113, respectively.34 Since the NmrA
structure was reported, however, several SDR
enzymes with SMK triads have been reported (e.g.,
WbpM from P. aeruginosa),26 so that the nonconser-
vation of the SDR catalytic triad in NmrA should not
rule out an enzyme function as absolutely as first
appeared.34 An alternative possibility to the biosyn-
thetic pathway we have outlined (Fig. 8) is that
WbmF does in fact catalyse either oxidation or
reduction as well as the 3,5-epimerisation, in which
case the third SDR may participate in O-antigen
expression by performing a function in the synthesis
of the complicated sugar residue that adorns the
nonreducing terminus of the O-chain.35 The non-Ac3NAcA catalysed by WbmF, WbmG and WbmH.
Table 3. Bacterial strains
Strain Description or genotype Reference
E. coli SM10λpir thi thr leu tonA lacY supE
recA∷RP4-2-Tc∷Mu kanrλpir
44
E. coli CC118 araD139, Δ(ara, leu)7697,
ΔlacX74, phoAΔ20, galE, galK,
thi, rpsE, rpoB, argEam, recA1
46
E. coli S17-1
pNJ5000
RP4 Res−, tra+, Tcr, pri, PstIC− 44,47
B. bronchiseptica
CN7635E
Wild type, Smr 51
B. bronchiseptica
CNF0a
wbmF∷Tcr, Smr This study
B. bronchiseptica
CNG1a
wbmG∷Tcr, Smr This study
B. bronchiseptica
CNH1d
wbmH∷Tcr, Smr This study
759SDR Enzymes in Bordetella O-antigen Biosynthesisredox role we propose for WbmF is consistent,
however, with the lack of the conserved SDR triad in
this enzyme, and if this protein operates purely as a
3,5-epimerase this may also suggest a mechanism by
which the wbmFmutant is able to express O antigen,
albeit in greatly reduced amounts. The product of the
initial oxidation reaction is activated for proton
exchange α- to the keto group and it may be that
racemisation at these positions occurs at a biologi-
cally significant rate without an absolute require-
ment for enzyme catalysis.
Recent structural studies of the 3,5-epimerase in
the dTDP-rhamnose pathway, RmlC,36 suggest that
the rate-limiting step in its reaction involves a
transition state in which the anomeric linkage is in
the disfavoured equatorial position (which is also
adopted by the reaction product), and that in order
to avoid steric clashes and satisfy the requirement for
axial proton abstraction, the reaction mechanism
requires a twist-boat conformation such as that
proposed in the GME reaction.12 Binding of sub-
strate in a C-1 equatorial conformation may be part
of the way that RmlC reduces kinetic barriers to this
reaction. For the same reasons, the product of the
proposed WbmF-catalysed 3,5-epimerisation will
have the nucleotide attached to the L-GalNAcNAcA
in the equatorial position in order to avoid 1,3,5-
triaxial clashes. This transformation therefore in-
volves considerable kinetic and thermodynamic
barriers and will be slow without enzyme catalysis.
However, if sufficient starting material is generated
by the upstream oxidase, and the 3,5-epimerisation
product is efficiently and selectively removed by the
downstream reductase, the flux through this bottle-
neck may be sufficient to allow O-chain synthesis.
Furthermore, the slower 3,5-epimerisation rate
resulting from mutation of the wbmF gene may
make relatively little impact onO-antigen expression
levels if this conversion does not usually comprise
the rate-limiting step for O-antigen synthesis. A
similar effect may operate in the dTDP-L-noviose
pathway in Streptomyces spheroides where observa-
tion of a naturally occurring L-rhamnoside analogue
of novobiocin37 shows that 3,5-epimerisation of the
dTDP-noviose precursor (dTDP-6-deoxy-D-xylo-4-
hexulose) does occur despite the fact that in vitro,
the 3,5-epimerisation catalysed byNovWhas a 2000-
fold lower kcat than RmlC38 (discussed in Ref. 39).
In conclusion, X-ray crystallography of WbmF,
WbmG and WbmH enabled definition of these
enzymes' NAD-cofactor preference and the sub-
strate nucleotide specificity. We have been able to
distinguish the likely function of WbmF from
WbmG and WbmH, but cannot differentiate the
roles of WbmG andWbmH. In order to achieve this,
these proteins must be characterised in vitro. This
will require chemical synthesis of UDP-D-Man-
NAc3NAcA and is beyond the scope of the present
study. Subject to future experimental verification of
predictions we have made, our data illustrate the
usefulness of structural studies for investigating
such challenging problems. While they also show
why this methodology cannot universally supplantdirect in vitro characterisation, this kind of structural
analysis will prove essential for researchers to make
full use of the gene databases.Materials and Methods
Bacterial strains, plasmids and culture conditions
Bacterial strains used in this study are described in
Table 3. Bordetella was grown on Bordet–Gengou agar
(Difco) supplemented with 10% defibrinated horse blood
(TCS Cellworks Ltd). E. coli was cultured in Luria–Bertani
(LB) broth or on LB agar. All strains were incubated at
37 °C and ampicillin (100 μg ml−1), kanamycin (50 μg
ml−1), tetracycline (10 μg ml−1 for E. coli, 5 μg ml−1 for
B. bronchiseptica) or streptomycin (200 μg ml−1) were
added where required. Suicide plasmids were based on
the host-restricted pEX100T backbone40 and broad host
range shuttle vectors were based on a Kmr derivative of
pBBR1MCS.41 For preparation of LPS, B. bronchiseptica
was grown in medium supplemented with 50 mM
MgSO4, as this maximises O-antigen expression in this
strain.
DNA methods
Standard methods were used for DNA manipulations.
Oligonucleotides were supplied by Sigma-Genosys. PCR
was performed with template from boiled bacteria42 and
Taq DNA polymerase (Promega) or KOD Hot Start DNA
polymerase (Novagen).
Construction of wbmF, wbmG and wbmH mutants
The multiple cloning site (MCS) from pBluescript II SK+
(Stratagene) was excised using SacI and KpnI, blunt-ended
and ligated into SmaI-cut pEX100T, to generate the MCS-
containing suicide vector pEXMCS. The wbmF allelic
exchange construct was prepared as follows. The wbmF
gene in the plasmid Bb540g06 (a clone generated in the
B. bronchiseptica RB50 genome sequencing project)43 was
disrupted by insertion of a blunt-ended tetracycline-
resistance (Tc) cassette into the internal NsiI site. The
mutant allele was excised using Acc65I and XbaI, blunt
ended, and then cloned into EcoRV-digested pEXMCS. For
760 SDR Enzymes in Bordetella O-antigen BiosynthesiswbmG, the gene was amplified using primers 5′-ATAT-
CTAGACATATGCGTATTCTGATCACCG-3′ (XbaI site
underlined) and 5′-ATAAAGCTTTGATTACTGGCAA-
CTCTTC-3′, and the PCR product was topoisomerase
cloned into pCR2.1-TOPO using a TOPO-cloning kit
(Invitrogen). wbmG was excised using XbaI and cloned
into the XbaI site in pEXMCS. The wbmG gene was then
disrupted by cloning a blunt-ended Tc cassette into the
internal Acc65I site. The wbmHmutant allele was obtained
by in vitro transposon-mediated mutagenesis of the wbm
locus-containing cosmid, BbLPS118 (accession number
AJ007747) using an EZ-Tn5™ bTet-1N insertion kit
(Epicentre). The bTet-1N transposon, plus flanking wbmH
DNA, was cut out by partial digestion with AluI and
ligated into SmaI-cut pEX100T. Allelic exchange constructs
were electroporated into E. coli SM10λpir and transferred
to B. bronchiseptica by conjugation with E. coli SM10λpir as
donor.44 Loss of the plasmid-encoded sacB gene in allelic
exchange mutagenesis of B. bronchiseptica was selected for
by growth on LB agar with reduced salt concentration and
supplemented with 10% (w/v) sucrose.45
Complementation of mutations
The B. bronchiseptica flaA promoter was amplified using
primers 5′-GCTCTAGATAGGCGCATGCCATGGCC-3′
(XbaI site underlined) and 5′-AAGGATCCCATATGGAG-
GCTCCCAAGAGAGAA-3′ (BamHI and NdeI sites
underlined), and cloned into the XbaI and BamHI sites
in pBBR1MCS-kan to generate the vector pCompEmpty.
wbmF was amplified using primers 5′-AAAAAAACATA-
TGTTGCCAGTAATCATGAATGC-3′ (NdeI site under-
lined) and 5′-AAAAAGCTTAGATCTAGTCCGCCGTCT-
TATTTG-3′ (HindIII site underlined) and cloned into
pCompEmpty using NdeI and HindIII to generate the
wbmF complementation vector pCompF. wbmG was PCR
amplified using primers 5′-AAAAAAACATATGCGTAT-
TCTGATCACC-3′ and 5′-AAAAAGCTTAGATCTGCAA-
CTCTTCAGGTCTTG-3′ and cloned into pCompEmpty
using NdeI and HindIII, generating pCompG. wbmH was
amplified using 5′-GAGAATTCCATATGAAGAAAGTAT-
TTATTACGG-3′ and 5′-AAAAAGCTTAGATCTTTGT-
CGATGACCAGGATT-3′ and cloned into pCompEmpty
using NdeI and HindIII, generating pCompH. Shuttle
vectors were moved into B. bronchiseptica by conjugation
with E. coli CC118 as donor46 and trans-acting transfer
functions provided by E. coli S17-1 pNJ5000 as helper.44,47
SDS-PAGE, silver stain and immunoblot analysis
of LPS
LPS was obtained from B. bronchiseptica using a modi-
fication of the method of Hitchcock and Brown48 as has
been described.49 SDS-PAGE of LPS was performed using
Novex precast 16% tricine gels (Invitrogen). LPS was
oxidised in-gel with periodic acid50 and visualised with
the Silver Stain Plus kit (BioRad). Western blotting was
performed as previously reported51 using the monoclonal
antibody D13B11 that specifically binds the O-antigen-
containing LPS of B. bronchiseptica strain CN7635E.35
X-ray crystallography
Protein production, purification, crystallisation and data
collection were performed as described.20 Data were
processed using DENZO and SCALEPACK (version
1.97).52 Data were truncated and converted to structurefactors using TRUNCATE53 from the CCP4 Suite.54 Mole-
cular replacement was carried out using PHASER55 as
described.20 For the initial WbmG structure, phases were
determined experimentally from selenomethionine-
labelled protein: peak, inflection point and high-energy
remote data were used to determine initial phases using
the PHENIX package.56 Model building was carried out
using COOT,57 and refinement was performed with
REFMAC version 5.0.58 Initial models were improved
using ARP/wARP version 6.1 where the data quality per-
mitted.59 The CCP4i interface60 was used where appro-
priate. TLS parameters were assigned (where used)
using the TLSMD server.61 CNS62 was used to perform
simulated annealing. Structures were validated using
COOT, PROCHECK,63WHATCHECK,64 andRAMPAGE.65
Table 2 provides a summary of the crystallographic sta-
tistics. Protein structures were analysed using Pymol,66
COOT,57 and CCP4MG.67 Surface area calculations were
performed using the Richards' Rolling Probe method.68
More extensive details of the crystallographic methods are
provided in the Supplementary Data.Modelling of putative substrate into WbmF structure
Coordinates and parameters for the 4-keto derivative of
UDP-2,3-dideoxy-2,3-diacetamido-D-mannuronic acid
were prepared using the CCP4 monomer library sketcher
with refinement in REFMAC 5.2.58 An initial structure was
prepared by modelling the proposed substrate into the
structure of WbmF co-crystallised with UDP in COOT.57
The observed density was used to place the atoms present
in UMP, and to place sugar atoms in positions occupied by
water or glycerol in the observed structure. Different
orientations were used in the two molecules in the
asymmetric unit to increase the sampling of conforma-
tional space. The structure of WbmF co-crystallised with
UDP, with 4-keto UDP-D-ManNAc3NAcA placed in, was
truncated to include only protein, NAD and 4-keto UDP-
D-ManNAc3NAcA atoms. This was used as an input to
MODELLER version 9.2 to determine an optimised
structure for the complex with the sugar nucleotide.69
After modelling, the ligand coordinates were regularised
in COOT to correct minor distortions. Ten modelling trials
were performed with different seeds, and the best was
selected by eye on the basis of geometry, agreement with
the determined structures and lack of bad interactions.Protein Data Bank accession codes
X-ray amplitudes, phases and the derived atomic
coordinates have been deposited with the PDB under the
accession codes 2PZJ, 2Q1T, 2Q1U, 2Q1S, 2PZK, 2PZL,
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